Membio
Scalable single-use bioreactors.
Mississauga, Canada · Founded 2018
- Headquarters
- Mississauga
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- membio.ca
- Last Round
- Pre-Seed
- Rounds
- 1
About
Membio developed proprietary single-use bioreactor technology purpose-built to enable cost-effective and scalable manufacturing of cells for cell therapy and gene therapy applications. Founded in 2018 in Mississauga, Ontario, the company focused on bioprocess development and R&D. In late 2023, Membio's bioreactor technology was acquired by ABEC Inc.
Summary
Membio is a Biotech company based in Mississauga, Canada, founded in 2018. Investors include IndieBio and SOSV.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/membio"><img src="https://indexed.vc/api/badge/company/membio" alt="Membio on Indexed.vc" width="260" height="76" /></a>